{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:26:26Z","timestamp":1790313986720,"version":"4.1.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>Topiramate-induced acute angle closure (TiAAC) is a potentially vision-threatening side effect of topiramate (TPM) use. The purpose of this article is to review demographic characteristics, clinical features, and management options of TiAAC. A systematic literature search of all reported cases and case series of TiAAC was conducted in the following search engines: PubMed, Web of Science, Google Scholar, Elsevier, and EBSCO. Seventy-three publications describing 77 cases were included. 58 (75.3%) patients were female, and the mean age was 34.88 \u00b1 11.21 years (range, 7\u201357). The most commonly reported indication of TPM use was migraine headache (59.7%), and the mean duration from starting treatment until the onset of angle closure was 14.1 \u00b1 31.5 days. All cases were managed by immediate cessation of TPM and topical therapy. In addition, systemic medications (carbonic anhydrase inhibitors, hyperosmotic agents, and steroids) were used in 51 patients (66.2%). A laser and\/or surgical intervention was performed in 10 patients (13%). After commencement of treatment, the mean duration until the resolution of TiAAC was 3.9 \u00b1 3.6 days (range, 1\u201318). The findings of our study present a summary of the current body of evidence provided by case reports and case series on TiAAC. In conclusion, the onset of angle closure following TPM use peaks at 2 weeks after initiating treatment, and in most cases, successful management can be achieved by discontinuing TPM and initiating appropriate medical therapy.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2134_21","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:53:23Z","timestamp":1652252003000},"page":"1491-1501","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Topiramate-induced acute angle closure: A systematic review of case reports and case series"],"prefix":"10.4103","volume":"70","author":[{"given":"Adi Mohammed","family":"Al Owaifeer","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Department of Surgery, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia"},{"name":"King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Mohammed","family":"AlSultan","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Surgery, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman H","family":"Badawi","sequence":"additional","affiliation":[{"name":"King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"R1-20251006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4137\/JCNSD.S4365","article-title":"Topiramate: Safety and efficacy of its use in the prevention and treatment of migraine","volume":"3","author":"Minton","year":"2011","journal-title":"J Cent Nerv Syst Dis"},{"key":"R2-20251006","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","article-title":"Topiramate-induced weight loss: A review","volume":"95","author":"Verrotti","year":"2011","journal-title":"Epilepsy Res"},{"key":"R3-20251006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.yebeh.2005.01.002","article-title":"Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy","volume":"6","author":"Fritz","year":"2005","journal-title":"Epilepsy Behav"},{"key":"R4-20251006","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1528-1167.2011.03245.x","article-title":"Incidence of kidney stones with topiramate treatment in pediatric patients","volume":"52","author":"Mahmoud","year":"2011","journal-title":"Epilepsia"},{"key":"R5-20251006","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OPTH.S27695","article-title":"Topiramate and the vision: A systematic review","volume":"6","author":"Abtahi","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R6-20251006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9394(82)90199-4","article-title":"The mechanism of transient myopia induced by sulfonamide therapy","volume":"94","author":"Bovino","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R7-20251006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/eye.1996.21","article-title":"Drug-induced ciliary body oedema: A new theory","volume":"10","author":"Krieg","year":"1996","journal-title":"Eye"},{"key":"R8-20251006","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R9-20251006","first-page":"00","article-title":"Topiramate induced bilateral simultaneous angle closure glaucoma in a steroid responder","volume":"1","author":"Adrian","year":"2015","journal-title":"Clin Ophthalmol Res"},{"key":"R10-20251006","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4103\/ijo.IJO_245_19","article-title":"Ciliochoroidal effusion in topiramate-induced bilateral acute angle closure glaucoma","volume":"67","author":"Agarwal","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R11-20251006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874364100802010046","article-title":"Topiramate induced acute angle closure glaucoma","volume":"2","author":"Aminlari","year":"2008","journal-title":"Open Ophthalmol J"},{"key":"R12-20251006","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4103\/MJDRDYPU.MJDRDYPU_288_16","article-title":"Topiramate-induced angle closure glaucoma in a case of chronic migraine","volume":"10","author":"Arun","year":"2017","journal-title":"Med J Dr DY Patil Univ"},{"key":"R13-20251006","first-page":"1092","article-title":"Topiramate induced sudden loss of vision","volume":"62","author":"Baloch","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"R14-20251006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9394(01)01013-3","article-title":"Presumed topiramate-induced bilateral acute angle-closure glaucoma","volume":"132","author":"Banta","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R15-20251006","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4103\/0028-3886.190232","article-title":"Topiramate-induced bilateral angle closure glaucoma and myopic shift","volume":"64","author":"Behl","year":"2016","journal-title":"Neurol India"},{"key":"R16-20251006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0028-3886.15074","article-title":"Acute myopia induced by topiramate: Report of a case and review of the literature","volume":"53","author":"Bhattacharyya","year":"2005","journal-title":"Neurol India"},{"key":"R17-20251006","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.WNL.0000091425.43083.C1","article-title":"Acute myopia and angle-closure glaucoma induced by topiramate","volume":"61","author":"Boentert","year":"2003","journal-title":"Neurology"},{"key":"R18-20251006","first-page":"1904","article-title":"Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report","volume":"91","author":"Boonyaleephan","year":"2008","journal-title":"J Med Assoc Thail"},{"key":"R19-20251006","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/jop.2011.0161","article-title":"Topiramate induced bilateral angle-closure glaucoma: Low dosage in a short time","volume":"28","author":"Caglar","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"R20-20251006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-2-1","article-title":"Acute bilateral simultaneous angle closure glaucoma after topiramate administration: A case report","volume":"2","author":"Chalam","year":"2008","journal-title":"J Med Case Rep"},{"key":"R21-20251006","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jemermed.2009.09.020","article-title":"Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: A case report","volume":"43","author":"Cole","year":"2012","journal-title":"J Emerg Med"},{"key":"R22-20251006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9394(03)00774-8","article-title":"Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma","volume":"137","author":"Craig","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R23-20251006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/IJG.0b013e3182948491","article-title":"Delayed topiramate-induced bilateral angle-closure glaucoma","volume":"23","author":"Czyz","year":"2014","journal-title":"J Glaucoma"},{"key":"R24-20251006","first-page":"116","article-title":"The use of topiramate for weight loss causing acute glaucoma: A case report and literature review","volume":"8","author":"DE Oliveira","year":"2019","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"R25-20251006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/0301-4738.27072","article-title":"Acute myopia and angle closure caused by topiramate, a drug used for prophylaxis of migraine","volume":"54","author":"Desai","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"R26-20251006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.oftal.2019.01.004","article-title":"Contribution of the Visante\u00aeOCT and B-scan ultrasound in the diagnosis and follow up of a topiramate-induced bilateral ciliochoroidal effusion syndrome","volume":"94","author":"Diaz-Cespedes","year":"2019","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R27-20251006","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3129\/i08-052","article-title":"Closed-angle glaucoma after topiramate therapy for migraine in a patient with undiagnosed pseudotumor cerebri","volume":"43","author":"Giuliari","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"R28-20251006","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/IJG.0000000000000157","article-title":"Bilateral angle closure following use of a weight loss combination agent containing topiramate","volume":"24","author":"Grewal","year":"2015","journal-title":"J Glaucoma"},{"key":"R29-20251006","doi-asserted-by":"crossref","first-page":"E1070","DOI":"10.1097\/OPX.0b013e31815b9e38","article-title":"Elevated intraocular pressure and myopic shift linked to topiramate use","volume":"84","author":"Guier","year":"2007","journal-title":"Optom Vis Sci"},{"key":"R30-20251006","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5301\/EJO.2010.5979","article-title":"Topiramate-induced acute bilateral angle closure and myopia: Pathophysiology and treatment controversies","volume":"21","author":"Issum C","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"R31-20251006","article-title":"A rare case of topiramate induced secondary acute angle closure glaucoma","volume":"11","author":"Joshi","year":"2017","journal-title":"J Clin Diagnostic Res"},{"key":"R32-20251006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10792-013-9793-8","article-title":"Topiramate-induced angle-closure glaucoma: Cross-sensitivity with other sulphonamide derivatives causing anterior uveitis","volume":"34","author":"Kamal","year":"2014","journal-title":"Int Ophthalmol"},{"key":"R33-20251006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-0034-1368282","article-title":"Bilateral severe anterior uveitis and acute angle-closure glaucoma following topiramate use for migraine crisis","volume":"231","author":"Katsimpris","year":"2014","journal-title":"Klin Monbl Augenheilkd"},{"key":"R34-20251006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40120-013-0008-z","article-title":"Bilateral acute angle-closure glaucoma following treatment with topiramate for headache","volume":"2","author":"Kulkarni","year":"2013","journal-title":"Neurol Ther"},{"key":"R35-20251006","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1444-0938.2012.00722.x","article-title":"Macular folds: An unusual association in topiramate toxicity","volume":"95","author":"Kumar","year":"2012","journal-title":"Clin Exp Optom"},{"key":"R36-20251006","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s10792-017-0740-y","article-title":"Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: Case report and literature review","volume":"38","author":"Lan","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R37-20251006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13760-012-0022-4","article-title":"Topiramate-induced acute myopia with MRI contrast enhancement","volume":"112","author":"Latini","year":"2012","journal-title":"Acta Neurol Belg"},{"key":"R38-20251006","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1139\/I06-012","article-title":"Topiramate-induced bilateral angle-closure glaucoma","volume":"41","author":"Levy","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R39-20251006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tjo.2012.12.005","article-title":"Topiramate-induced bilateral secondary angle closure and myopia shift","volume":"4","author":"Lin","year":"2014","journal-title":"Taiwan J Ophthalmol"},{"key":"R40-20251006","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4103\/ijo.IJO_1192_17","article-title":"Topiramate-induced acute angle closure with severe panuveitis: A challenging case report","volume":"66","author":"Mahendradas","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R41-20251006","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1600-0420.2005.00534.x","article-title":"Bilateral angle-closure glaucoma following oral topiramate therapy","volume":"83","author":"Mansoor","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"R42-20251006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1120672118797286","article-title":"Acquired myopia followed by acquired hyperopia due to serous neurosensory retinal detachment following topiramate intake","volume":"29","author":"Mazumdar","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"R43-20251006","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archopht.121.2.282","article-title":"Angle-closure glaucoma associated with ciliary body detachment in patients using topiramate","volume":"121","author":"Medeiros","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R44-20251006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/0301-4738.129784","article-title":"Anterior segment optical coherence tomography documentation of a case of topiramate induced acute angle closure","volume":"62","author":"Mitra","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R45-20251006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-620X.60018","article-title":"Topiramate-induced angle closure with acute myopia, macular straie","volume":"3","author":"Natesh","year":"2010","journal-title":"Oman J Ophthalmol"},{"key":"R46-20251006","first-page":"224","article-title":"Idiosyncratic topiramate-induced high myopic shift with angle closure glaucoma","volume":"28","author":"Nizamani","year":"2012","journal-title":"Pak J Ophthalmol"},{"key":"R47-20251006","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omy030","article-title":"Case report: The role of OCT in examination of a patient with topiramate-induced acute angle closure, acute myopia and macular striae","author":"Osaba","year":"2018","journal-title":"Oxf Med Case Reports 2018"},{"key":"R48-20251006","first-page":"1","article-title":"Secondary bilateral angle closure glaucoma due to topiramate","volume":"2011","author":"Paciuc-Beja","year":"2011","journal-title":"Case Rep Ophthalmol Med"},{"key":"R49-20251006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0019-5545.82552","article-title":"Glaucoma: Adverse event on use of topiramate in alcohol de-addiction","volume":"53","author":"Pai","year":"2011","journal-title":"Indian J Psychiatry"},{"key":"R50-20251006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3129\/i07-092","article-title":"Optical coherence tomography for diagnosis and monitoring of angle-closure glaucoma induced by topiramate","volume":"42","author":"Palomares","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"R51-20251006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/IJG.0b013e318098739b","article-title":"Choroidal drainage in the management of acute angle closure after topiramate toxicity","volume":"16","author":"Parikh","year":"2007","journal-title":"J Glaucoma"},{"key":"R52-20251006","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-203787","article-title":"Acute bilateral glaucoma and panuveitis as a side effect of topiramate for weight loss treatment","author":"Pikkel","year":"2014","journal-title":"BMJ Case Rep 2014"},{"key":"R53-20251006","first-page":"159","article-title":"Acute myopia and secondary angle closure glaucoma following topiramate medication","volume":"13","author":"Prakash","year":"2010","journal-title":"Delhi Psychiatry J"},{"key":"R54-20251006","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0004-27492013000100014","article-title":"Topiramate-associated acute, bilateral, angle-closure glaucoma: Case report","volume":"76","author":"Quagliato","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"R55-20251006","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5455\/2319-2003.ijbcp20140628","article-title":"Topiramate-induced bilateral acute angle closure glaucoma and myopic shift","volume":"3","author":"Raj","year":"2014","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R56-20251006","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/OPTH.S65748","article-title":"Intermittent acute angle closure glaucoma and chronic angle closure following topiramate use with plateau iris configuration","volume":"8","author":"Rajjoub","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R57-20251006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2431-14-96","article-title":"Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: A case report and review of the literature","volume":"14","author":"Rapoport","year":"2014","journal-title":"BMC Pediatr"},{"key":"R58-20251006","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/ceo.12336","article-title":"Utility of ultrasound biomicroscopy in the diagnosis of topiramate-associated ciliochoroidal effusions causing bilateral acute angle closure","volume":"42","author":"Reis","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"R59-20251006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1658-600X.126062","article-title":"Topiramate-induced secondary angle closure","volume":"2","author":"Rewri","year":"2014","journal-title":"J Heal Spec"},{"key":"R60-20251006","first-page":"1721","article-title":"Bilateral angle-closure glaucoma and ciliary body swelling from topiramate","volume":"119","author":"Rhee","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R61-20251006","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ajo.2006.01.021","article-title":"Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol","volume":"141","author":"Rhee","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R62-20251006","first-page":"57","article-title":"Angle closure and myopic shift after topiramate used for appetite control","volume":"16","author":"Rodr\u00edguez","year":"2017","journal-title":"Pan-American J Ophthalmol"},{"key":"R63-20251006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajoc.2017.05.005","article-title":"Topiramate-induced macular neurosensory retinal detachment","volume":"7","author":"Rosenberg","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R64-20251006","first-page":"72","article-title":"Topiramate induced secondary angle closure glaucoma","volume":"52","author":"Sachi","year":"2006","journal-title":"J Postgrad Med"},{"key":"R65-20251006","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006509","article-title":"Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings","author":"Saffra","year":"2012","journal-title":"BMJ Case Rep 2012"},{"key":"R67-20251006","first-page":"1","article-title":"Topiramate-induced acute bilateral angle closure glaucoma and transient myopia: A teaching case report","volume":"40","author":"Santos-Nevarez","year":"2015","journal-title":"J Optom Educ"},{"key":"R68-20251006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/IJG.0b013e31818159e9","article-title":"Argon laser peripheral iridoplasty for topiramate-induced bilateral acute angle closure","volume":"18","author":"Sbeity","year":"2009","journal-title":"J Glaucoma"},{"key":"R69-20251006","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0301-4738.62657","article-title":"Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: A case series","volume":"58","author":"Senthil","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"R70-20251006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/tjosr.tjosr_73_19","article-title":"Aftermath of topiramate: An interesting case report and literature review","volume":"57","author":"Senthilkumar","year":"2019","journal-title":"TNOA J Ophthalmic Sci Res"},{"key":"R71-20251006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.oftal.2018.11.005","article-title":"Acute narrow-angle glaucoma induced by topiramate with acute myopia and macular striae: A case report","volume":"94","author":"Sierra-Rodr\u00edguez","year":"2019","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R72-20251006","first-page":"234","article-title":"Topiramate induced bilateral angle-closure glaucoma","volume":"5","author":"Singh","year":"2007","journal-title":"Kathmandu Univ Med J"},{"key":"R73-20251006","first-page":"49","article-title":"Topiramate induced bilateral angle-closure glaucoma","volume":"20","author":"Sorkhabi","year":"2008","journal-title":"Iran J Ophthalmol"},{"key":"R74-20251006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1757-1626-2-87","article-title":"Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: A case-report","volume":"2","author":"Spaccapelo","year":"2009","journal-title":"Cases J"},{"key":"R75-20251006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1590\/S0004-27492007000100025","article-title":"Bilateral acute angle closure glaucoma in a young patient receiving oral topiramate: Case report","volume":"70","author":"Stangler","year":"2007","journal-title":"Arq Bras Oftalmol"},{"key":"R76-20251006","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1097\/MJT.0000000000001004","article-title":"Topiramate-associated acute angle closure glaucoma with myopic shift","volume":"27","author":"Tambe","year":"2020","journal-title":"Am J Ther"},{"key":"R77-20251006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/practneurol-2015-001363","article-title":"Topiramate-induced acute glaucoma","volume":"16","author":"Vahdani","year":"2016","journal-title":"Pract Neurol"},{"key":"R78-20251006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0972-0200.376620","article-title":"Acute onset myopia and angle closure glaucoma after topiramate administration","volume":"21","author":"Verma","year":"2011","journal-title":"Delhi J Ophthalmol"},{"key":"R79-20251006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2006-926600","article-title":"Blood-brain barrier disruption associated with topiramate-induced angle-closure glaucoma of acute onset","volume":"223","author":"Viet Tran","year":"2006","journal-title":"Klin Monbl Augenheilkd"},{"key":"R80-20251006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1752-1947-5-33","article-title":"Refractory topiramate-induced angle-closure glaucoma in a man: A case report","volume":"5","author":"Willett","year":"2011","journal-title":"J Med Case Rep"},{"key":"R81-20251006","first-page":"831","article-title":"Typical migraine or ophthalmologic emergency?","volume":"30","author":"Ybarra","year":"2012","journal-title":"J Emerg Med"},{"key":"R82-20251006","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: Data from the American migraine study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"R83-20251006","first-page":"775","article-title":"Case reports and small case series: Topiramate-induced acute myopia and retinal striae","volume":"119","author":"Sen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R84-20251006","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MJT.0000000000001045","article-title":"Acetazolamide-associated idiosyncratic simultaneous bilateral angle closure and cross-sensitivity","volume":"27","author":"Pathak-Ray","year":"2020","journal-title":"Am J Ther"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2134_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:51:47Z","timestamp":1786647107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2134_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2134_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"2021-08-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}